SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Jim B who wrote (1151)6/18/1998 11:22:00 AM
From: StandFast  Respond to of 5402
 
Anyone,
Hows the buy/sell ratio looking?

How can they keep the price stagnate if there are so many buys?



To: Jim B who wrote (1151)6/18/1998 11:27:00 AM
From: Hyrulean King  Respond to of 5402
 
Jim it's interesting how the demoters focus on the 1st gen product when it's the 2nd gen improved product that is the company's focus at this point. Did you hear a 'peep' i think the pigeons have turned into chicks.

chief



To: Jim B who wrote (1151)6/18/1998 11:48:00 AM
From: RocketMan  Read Replies (1) | Respond to of 5402
 
Folks, SGNC just got instant credibility in the biotech field. Batelle, one of the leading medical research laboratories, does not go around signing up companies with a weak idea or product. Now, just how soon do you think the major pharmaceuticals might start paying attention? Mmmm....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News